These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31272014)

  • 21. Altered Lateral Prefrontal Cortex Functioning During Emotional Interference Resistance Is Associated With Affect Lability in Adults With Persisting Symptoms of Attention-Deficit/Hyperactivity Disorder From Childhood.
    Ojha A; Jones NP; Henry T; Versace A; Gnagy EM; Joseph HM; Molina BSG; Ladouceur CD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jun; 9(6):588-596. PubMed ID: 38378127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sluggish cognitive tempo and ADHD symptoms in relation to task-unrelated thought: Examining unique links with mind-wandering and rumination.
    Fredrick JW; Kofler MJ; Jarrett MA; Burns GL; Luebbe AM; Garner AA; Harmon SL; Becker SP
    J Psychiatr Res; 2020 Apr; 123():95-101. PubMed ID: 32045730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary examination of ADHD inattentive and cognitive disengagement syndrome symptoms in relation to probe-caught mind-wandering during a sustained attention to response task.
    Wiggs KK; Fredrick JW; Tamm L; Epstein JN; Simon JO; Becker SP
    J Psychiatr Res; 2024 Apr; 172():181-186. PubMed ID: 38394764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Neuropsychiatric Function in Phenylketonuria: Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria.
    Wyrwich KW; Auguste P; Yu R; Zhang C; Dewees B; Winslow B; Yu S; Merilainen M; Prasad S
    Value Health; 2015 Jun; 18(4):404-12. PubMed ID: 26091594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do Personality Traits Predict Functional Impairment and Quality of Life in Adult ADHD? A Controlled Study.
    He JA; Antshel KM; Biederman J; Faraone SV
    J Atten Disord; 2019 Jan; 23(1):12-21. PubMed ID: 26610740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of an Ecological Executive Skill Training Program for School-aged Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Clinical Trial.
    Qian Y; Chen M; Shuai L; Cao QJ; Yang L; Wang YF
    Chin Med J (Engl); 2017 Jul; 130(13):1513-1520. PubMed ID: 28639564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-Awareness of Executive Functioning Deficits in Adolescents With ADHD.
    Steward KA; Tan A; Delgaty L; Gonzales MM; Bunner M
    J Atten Disord; 2017 Feb; 21(4):316-322. PubMed ID: 24799318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
    J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale.
    Silverstein MJ; Faraone SV; Alperin S; Biederman J; Spencer TJ; Adler LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):339-349. PubMed ID: 29172673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.
    Durell TM; Adler LA; Williams DW; Deldar A; McGough JJ; Glaser PE; Rubin RL; Pigott TA; Sarkis EH; Fox BK
    J Clin Psychopharmacol; 2013 Feb; 33(1):45-54. PubMed ID: 23277268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder.
    Surman CBH; Robertson B; Chen J; Cortese S
    CNS Drugs; 2019 Jul; 33(7):695-706. PubMed ID: 31228031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADHD and executive functioning deficits in OCD youths who hoard.
    Park JM; Samuels JF; Grados MA; Riddle MA; Bienvenu OJ; Goes FS; Cullen B; Wang Y; Krasnow J; Murphy DL; Rasmussen SA; McLaughlin NC; Piacentini J; Pauls DL; Stewart SE; Shugart YY; Maher B; Pulver AE; Knowles JA; Greenberg BD; Fyer AJ; McCracken JT; Nestadt G; Geller DA
    J Psychiatr Res; 2016 Nov; 82():141-8. PubMed ID: 27501140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mind-wandering in children with and without ADHD.
    Frick MA; Asherson P; Brocki KC
    Br J Clin Psychol; 2020 Jun; 59(2):208-223. PubMed ID: 31880828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in older adults with ADHD: links to ADHD symptom levels and executive functioning deficits.
    Thorell LB; Holst Y; Sjöwall D
    Nord J Psychiatry; 2019 Oct; 73(7):409-416. PubMed ID: 31380715
    [No Abstract]   [Full Text] [Related]  

  • 36. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study.
    Surman CB; Biederman J; Spencer T; Miller CA; McDermott KM; Faraone SV
    Atten Defic Hyperact Disord; 2013 Sep; 5(3):273-81. PubMed ID: 23413201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Mind-Wandering Explain ADHD-Related Impairment in Adolescents?
    Dekkers TJ; Flisar A; Karami Motaghi A; Karl A; Frick MA; Boyer BE
    Child Psychiatry Hum Dev; 2023 Jun; ():. PubMed ID: 37382726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention.
    Faraone SV; Rostain AL; Blader J; Busch B; Childress AC; Connor DF; Newcorn JH
    J Child Psychol Psychiatry; 2019 Feb; 60(2):133-150. PubMed ID: 29624671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
    Adler LA; Dirks B; Deas PF; Raychaudhuri A; Dauphin MR; Lasser RA; Weisler RH
    J Clin Psychiatry; 2013 Jul; 74(7):694-702. PubMed ID: 23945447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention-deficit/hyperactivity disorder symptoms in adults with self-reported epilepsy: Results from a national epidemiologic survey of epilepsy.
    Ettinger AB; Ottman R; Lipton RB; Cramer JA; Fanning KM; Reed ML
    Epilepsia; 2015 Feb; 56(2):218-24. PubMed ID: 25594106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.